Retrievable & PermanentA B L E PROVEN & RELI Retrievable Vena Cava Filter
Open the catalog to page 1Product Overview Retrievable Vena Cava Filter Leave It In. Take It Out. Your Choice. Our Advantage. Safe Profile • ow profile, 6F delivery system L • emoval is optional for up to 12 days R • ix potential access points S • obust design for long term durability R • D emonstrated low complication rates across multiple clinical studies • esign helps reduce risks known to D retrievable filters • P ROOF results demonstrate low rate of
Open the catalog to page 2FDA Recommendations for Retrieval Shorter Retrieval Window FDA Recommendation1: Between 1 and 2 months the risk-benefit profile favors removal of the filter if the patient's transient risk for PE has passed. The Problem: In 2014, the FDA issued a Safety Communication highlighting concern about adverse events reported with vena cava filters, noting that some complications may The Cordis Solution: The Cordis OPTEASE™ Retrievable Vena Cava Filter can be removed up to 12 days from the date of implantation and is proven to have low complication rates. Cordis uPTeasi Retrievable Vena Cava Filter LOW...
Open the catalog to page 3Designed to Deliver Performance and Stability for Every Patient Six Insertion Sites For ease of use Fixation Barbs including femoral, Minimize migration veins bilaterally capture efficiency Closed Cage Designed to eliminate risk of caval perforation and strut embolization Eliminates risk of arm entanglement Side Struts Self centering upon insertion reduces the risk of tilting Dual Prong Caudal Hook For easier snare capture
Open the catalog to page 4Design Specifications Fixation Barbs • Minimize risk of migration to maintain clot capture efficiency • "Ski Barb" design resists cranial migration which can lead to serious complications • Location at upper pole allows for earlier wall apposition when placed via femoral access Back to Performance Page
Open the catalog to page 5Design Specifications • Dual prong hook designed for easier snare capture • Femoral retrieval route avoids passing through the heart • 12 day retrieval Back to Performance Page
Open the catalog to page 6Design Specifications Side Struts • Self centering upon insertion, reducing the risk of tilting which can decrease clot capture efficiency • Dual Prong Caudal Hook for easier capture with any appropriate endovascular snare • Minimize risk of migration providing caval wall contact earlier in the deployment process than other designs Back to Performance Page
Open the catalog to page 7Design Specifications Closed Cage Design Fully connected structure designed to eliminate the risk of caval perforation by needle-like arms Designed to eliminate strut embolization after fracture of a single strut segment Eliminates risk of struts becoming entangled, thereby leaving a gap between struts Back to Performance Page
Open the catalog to page 8Here’s the PROOF Study results : A Demonstration of Safety that Results in Confidence In the prospective, multi-center, single filter, trial with 150 patients at 11 U.S. sites, the OPTEASE Vena Cava Filter had no reports of symptomatic PE, caval perforation or strut embolization1. ™ Symptomatic PE Caval Penetration Strut Embolization Results from this study show that the OPTEASE Retrievable Vena Cava Filter can be safely used as a permanent filter in patients at high risk for pulmonary embolism. ™ Fewer than 1% of patients experienced filter migration or new thrombus formation with the OPTEASE...
Open the catalog to page 9Clinical Studies One of The Most Tested Filter on The Market OPTEASE Retrievable Vena Cava Filter PROOF Trial: Protection from Pulmonary Embolism with the Cordis OPTEASE Retrievable Vena Cava Filter1 ™ Click Here for PROOF Publicatio
Open the catalog to page 10OPTEASE™ Retrievable Vena Cava Filter Cordis OPTEASE™ Retrievable Vena Cava Filter Ordering Information Cordis OPTEASE™ Vena Cava Filter and Introduction Kit (55 cm) Femoral 466-F210AF Cordis OPTEASE™ Vena Cava Filter and Introduction Kit (55 cm) Jugular 466-F210AJ Cordis OPTEASE™ Vena Cava Filter and Introduction Kit (90 cm) Antecubital, Jugular 466-F210BJ ’Ziegler, JW et al. PROOF Trial: Protection from Pulmonary Embolism with the OPTEASE™ Filter. JVIR 2008; 19:1165-1170. WARNING: Implant of the OPTEASE™ Vena Cava Filter with the hook oriented in the cranial direction can result in life threatening...
Open the catalog to page 114 Pages
4 Pages
129 Pages
7 Pages
23 Pages
2 Pages
2 Pages
38 Pages
3 Pages
4 Pages
10 Pages
12 Pages
10 Pages
3 Pages
2 Pages
3 Pages
112 Pages
6 Pages
22 Pages
123 Pages
2 Pages
2 Pages
16 Pages
4 Pages
4 Pages
11 Pages
2 Pages
4 Pages
146 Pages